247 related articles for article (PubMed ID: 26727382)
1. Changes in Practice Patterns of Clopidogrel in Combination with Proton Pump Inhibitors after an FDA Safety Communication.
Guérin A; Mody R; Carter V; Ayas C; Patel H; Lasch K; Wu E
PLoS One; 2016; 11(1):e0145504. PubMed ID: 26727382
[TBL] [Abstract][Full Text] [Related]
2. Changes in CYP2C19 enzyme activity evaluated by the [(13)C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity.
Harvey A; Modak A; Déry U; Roy M; Rinfret S; Bertrand OF; Larose É; Rodés-Cabau J; Barbeau G; Gleeton O; Nguyen CM; Proulx G; Noël B; Roy L; Paradis JM; De Larochellière R; Déry JP
J Breath Res; 2016 Jan; 10(1):017104. PubMed ID: 26815196
[TBL] [Abstract][Full Text] [Related]
3. Proton-pump inhibitors in patients requiring antiplatelet therapy: new FDA labeling.
Johnson DA; Chilton R; Liker HR
Postgrad Med; 2014 May; 126(3):239-45. PubMed ID: 24918808
[TBL] [Abstract][Full Text] [Related]
4. A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers.
Frelinger AL; Lee RD; Mulford DJ; Wu J; Nudurupati S; Nigam A; Brooks JK; Bhatt DL; Michelson AD
J Am Coll Cardiol; 2012 Apr; 59(14):1304-11. PubMed ID: 22464259
[TBL] [Abstract][Full Text] [Related]
5. Effects of rabeprazole on the antiplatelet effects and pharmacokinetics of clopidogrel in healthy volunteers.
Funck-Brentano C; Szymezak J; Steichen O; Ducint D; Molimard M; Remones V; Azizi M; Gaussem P
Arch Cardiovasc Dis; 2013 Dec; 106(12):661-71. PubMed ID: 24246616
[TBL] [Abstract][Full Text] [Related]
6. Influence of low-dose proton pump inhibitors administered concomitantly or separately on the anti-platelet function of clopidogrel.
Furuta T; Sugimoto M; Kodaira C; Nishino M; Yamade M; Uotani T; Sahara S; Ichikawa H; Kagami T; Iwaizumi M; Hamaya Y; Osawa S; Sugimoto K; Umemura K
J Thromb Thrombolysis; 2017 Apr; 43(3):333-342. PubMed ID: 27981489
[TBL] [Abstract][Full Text] [Related]
7. Trends in concomitant clopidogrel and proton pump inhibitor treatment among ACS inpatients, 2000-2016.
Farhat N; Haddad N; Crispo J; Birkett N; McNair D; Momoli F; Wen SW; Mattison DR; Krewski D
Eur J Clin Pharmacol; 2019 Feb; 75(2):227-235. PubMed ID: 30324301
[TBL] [Abstract][Full Text] [Related]
8. Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors.
Leonard CE; Bilker WB; Brensinger CM; Flockhart DA; Freeman CP; Kasner SE; Kimmel SE; Hennessy S
Stroke; 2015 Mar; 46(3):722-31. PubMed ID: 25657176
[TBL] [Abstract][Full Text] [Related]
9. East Asian perspective on the interaction between proton pump inhibitors and clopidogrel.
Zou D; Goh KL
J Gastroenterol Hepatol; 2017 Jun; 32(6):1152-1159. PubMed ID: 28024166
[TBL] [Abstract][Full Text] [Related]
10. No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis.
Kwok CS; Jeevanantham V; Dawn B; Loke YK
Int J Cardiol; 2013 Aug; 167(3):965-74. PubMed ID: 22464478
[TBL] [Abstract][Full Text] [Related]
11. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.
Sibbing D; Morath T; Stegherr J; Braun S; Vogt W; Hadamitzky M; Schömig A; Kastrati A; von Beckerath N
Thromb Haemost; 2009 Apr; 101(4):714-9. PubMed ID: 19350116
[TBL] [Abstract][Full Text] [Related]
12. [Impact of pharmacotherapeutic warnings on the prescription of clopidogrel and proton pump inhibitors in hospitalised patients].
Sánchez Ruiz-Gordoa M; Tenías Burillo JM; Ruiz Martín de la Torre R; Valenzuela Gámez JC
Farm Hosp; 2012; 36(4):250-5. PubMed ID: 22118768
[TBL] [Abstract][Full Text] [Related]
13. [Proton pump inhibitors and clopidogrel: a hazardous association?].
Szymezak J; Gaussem P
Rev Med Interne; 2013 Feb; 34(2):99-104. PubMed ID: 23200799
[TBL] [Abstract][Full Text] [Related]
14. Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial.
Nicolau JC; Bhatt DL; Roe MT; Lokhnygina Y; Neely B; Corbalán R; Leiva-Pons JL; Martinez F; Goodman SG; Winters KJ; Verheugt FW; Armstrong PW; White HD; Fox KA; Prabhakaran D; Ohman EM;
Am Heart J; 2015 Oct; 170(4):683-694.e3. PubMed ID: 26386792
[TBL] [Abstract][Full Text] [Related]
15. Clopidogrel and proton pump inhibitor (PPI) interaction: separate intake and a non-omeprazole PPI the solution?
Kenngott S; Olze R; Kollmer M; Bottheim H; Laner A; Holinski-Feder E; Gross M
Eur J Med Res; 2010 May; 15(5):220-4. PubMed ID: 20562062
[TBL] [Abstract][Full Text] [Related]
16. Omeprazole, but not pantoprazole, reduces the antiplatelet effect of clopidogrel: a randomized clinical crossover trial in patients after myocardial infarction evaluating the clopidogrel-PPIs drug interaction.
Fontes-Carvalho R; Albuquerque A; Araújo C; Pimentel-Nunes P; Ribeiro VG
Eur J Gastroenterol Hepatol; 2011 May; 23(5):396-404. PubMed ID: 21464720
[TBL] [Abstract][Full Text] [Related]
17. Predictors and time trends in clopidogrel and proton pump inhibitor coprescription with low-dose acetylsalicylic acid.
Cea Soriano L; Bueno H; Johansson S; García Rodríguez LA
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):463-9. PubMed ID: 22298501
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitor and clopidogrel interaction: fact or fiction?
Laine L; Hennekens C
Am J Gastroenterol; 2010 Jan; 105(1):34-41. PubMed ID: 19904241
[TBL] [Abstract][Full Text] [Related]
19. Review article: combination of clopidogrel and proton pump inhibitors: implications for clinicians.
Tran M; Tafreshi J; Pai RG
J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):326-37. PubMed ID: 20938037
[TBL] [Abstract][Full Text] [Related]
20. Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study.
Cuisset T; Frere C; Quilici J; Poyet R; Gaborit B; Bali L; Brissy O; Morange PE; Alessi MC; Bonnet JL
J Am Coll Cardiol; 2009 Sep; 54(13):1149-53. PubMed ID: 19761935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
